PURPOSE OF REVIEW: In this article, we review the pathogenesis, clinical features, imaging modalities and latest management options for optic pit maculopathy (OPM). RECENT FINDINGS: The pathogenesis of OPM remains to be unclear, but imaging tools such as optical coherence tomography (OCT) and OCT angiography are enhancing our knowledge. Observation continues to be the best management strategy for patients with good visual acuity, and many cases have demonstrated spontaneous resolution. For more advanced, progressive vision loss, treatment options involving vitrectomy can be considered and discussed with the patient. Supplementary techniques to vitrectomy have been reported in small studies with relative success such as glial tissue peeling, inverted internal limiting membrane flap, optic pit plugging, and retinal fenestration. SUMMARY: While there are multiple treatment options available for OPM, there is no consensus on the technique and surgical timing. Individual patient factors and the risks-benefits of treatment must be taken into account in guiding management. Larger clinical trials will further assist in decision making for treating OPM.
PURPOSE OF REVIEW: In this article, we review the pathogenesis, clinical features, imaging modalities and latest management options for optic pit maculopathy (OPM). RECENT FINDINGS: The pathogenesis of OPM remains to be unclear, but imaging tools such as optical coherence tomography (OCT) and OCT angiography are enhancing our knowledge. Observation continues to be the best management strategy for patients with good visual acuity, and many cases have demonstrated spontaneous resolution. For more advanced, progressive vision loss, treatment options involving vitrectomy can be considered and discussed with the patient. Supplementary techniques to vitrectomy have been reported in small studies with relative success such as glial tissue peeling, inverted internal limiting membrane flap, optic pit plugging, and retinal fenestration. SUMMARY: While there are multiple treatment options available for OPM, there is no consensus on the technique and surgical timing. Individual patient factors and the risks-benefits of treatment must be taken into account in guiding management. Larger clinical trials will further assist in decision making for treating OPM.
Entities:
Keywords:
Optic pit maculopathy; congenital optic pit; lamina cribosa; maculopathy; optic pit; pars plana vitrectomy
Authors: P G Theodossiadis; V G Grigoropoulos; J Emfietzoglou; P Nikolaidis; G P Theodossiadis Journal: Eur J Ophthalmol Date: 2007 Mar-Apr Impact factor: 2.597
Authors: David H W Steel; Javid Suleman; Declan C Murphy; Anna Song; Steve Dodds; Jon Rees Journal: Ophthalmology Date: 2018-06-07 Impact factor: 12.079
Authors: Nicolas A Yannuzzi; Xiao Yi Zhou; Pedro Monsalve; Sander R Dubovy; William E Smiddy Journal: Ophthalmic Surg Lasers Imaging Retina Date: 2018-12-01 Impact factor: 1.300